Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

50
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
50
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

6.4K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved prostate diffusion imaging using deep learning denoising and phase correction with ultra-high-density coil array.

Radiology advances·2026
Same author

Population arterial input function measured from low dose breast ultrafast dynamic contrast enhanced MRI and fitted with a new mathematic model.

Magnetic resonance imaging·2026
Same author

Automated Cluster-based Quantitative Analysis of Ultrafast DCE MRI for Differential Breast DCIS Grading.

Radiology. Imaging cancer·2026
Same author

K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy.

Journal of applied clinical medical physics·2025
Same author

Next-Generation Advances in Prostate Cancer Imaging and Artificial Intelligence Applications.

Journal of imaging·2025
Same author

Ultrafast breast DCE-MRI: comparative analysis of semi-quantitative and pharmacokinetic parameters with gadoterate meglumine versus gadobutrol in malignant lesions and background parenchymal enhancement.

Quantitative imaging in medicine and surgery·2025

Related Experiment Video

Updated: Sep 3, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

365

Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus

Grace H Lee1, Aritrick Chatterjee1, Ibrahim Karademir1

  • 1From the Department of Radiology (G.H.L., A.C., I.K., R.E., A.Y., C.B.H., G.S.K., A.O.), Sanford J. Grossman Center of Excellence in Prostate Imaging and Image Guided Therapy (G.H.L., A.C., R.E., A.Y., C.B.H., G.S.K., A.O.), and Department of Public Health Sciences (M.G.), University of Chicago, 5841 S Maryland Ave, MC 2026, Chicago, IL 60637.

Radiology
|July 26, 2022
PubMed
Summary

Hybrid multidimensional MRI (HM-MRI) offers improved objectivity for diagnosing prostate cancer compared to standard multiparametric MRI (mpMRI). HM-MRI demonstrated higher specificity, better interobserver agreement, and reduced interpretation time, aiding in the detection of clinically significant prostate cancer.

More Related Videos

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

Related Experiment Videos

Last Updated: Sep 3, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

365
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.3K

Area of Science:

  • Radiology and Medical Imaging
  • Oncology
  • Prostate Cancer Diagnostics

Background:

  • Prostate multiparametric MRI (mpMRI) interpretation shows variability due to reader experience and subjective lesion characterization, despite PI-RADS v2.1 guidelines.
  • Hybrid multidimensional MRI (HM-MRI) presents a potential quantitative solution to enhance objectivity in prostate MRI analysis.

Purpose of the Study:

  • To compare the diagnostic performance, interobserver agreement, and interpretation time of radiologists using mpMRI versus HM-MRI for clinically significant prostate cancer.
  • To evaluate the effectiveness of HM-MRI in standardizing prostate cancer diagnosis.

Main Methods:

  • Retrospective analysis of 61 men with confirmed prostate cancer who underwent both mpMRI and HM-MRI.
  • Four radiologists with varying experience independently interpreted both MRI types, with PI-RADS scores and interpretation times recorded.
  • Statistical comparison of diagnostic performance (AUC), interobserver agreement (Cronbach alpha), and interpretation time between mpMRI and HM-MRI.

Main Results:

  • HM-MRI showed higher per-patient specificity for readers 2-4 and improved AUC for reader 4 compared to mpMRI.
  • HM-MRI significantly enhanced interobserver agreement (Cronbach alpha = 0.88) compared to mpMRI (Cronbach alpha = 0.26).
  • Mean interpretation time for HM-MRI (73 seconds) was substantially shorter than for mpMRI (254 seconds).

Conclusions:

  • Radiologists achieved similar or improved diagnostic performance for clinically significant prostate cancer using HM-MRI compared to mpMRI.
  • HM-MRI offers superior interobserver agreement and reduced interpretation time, making it a more objective and efficient diagnostic tool.
  • HM-MRI shows promise in overcoming the limitations of subjective interpretation in prostate cancer assessment.